Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthieu Sarabi

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Hepatobiliary Surgery and Nutrition|December 12, 2025
Biliary tract cancers: topaz-1 up-date, a practice changing studyMatthieu Sarabi, Pascal Artru
Bulletin Du Cancer|May 19, 2023
[New drug approval: Durvalumab in combinaison with cisplatin and gemcitabine in first-line in patient with advanced biliary tract cancer]Laure Blondet, Matthieu Sarabi
Joint Bone Spine|June 5, 2013
Online home self-assessment: a tool for improving future treatment trials… and daily practice: comments on the editorial by Berthelot JM, et al. "Online home self-assessment: a tool for improving future treatment trials?", Joint Bone Spine 2013;80:5-7Yvan Jamilloux, Matthieu Sarabi
European Journal of Cancer (Oxford, England : 1990)|December 4, 2022
Cholangiocarcinoma: what are the options in all comers and how has the advent of molecular profiling opened the way to personalised medicine ?Gael S Roth, Cindy Neuzillet, Matthieu Sarabi, et al.
Biomedical Reports|January 27, 2017
Psychoactive drugs influence brain-derived neurotrophic factor and neurotrophin 4/5 levels in the serum of colorectal cancer patientsMatthieu Sarabi, Aurélie Perraud, Clément Mazouffre, et al.
Oncology Letters|June 11, 2017
Use of gemcitabine as a second-line treatment following chemotherapy with folfirinox for metastatic pancreatic adenocarcinomaMatthieu Sarabi, Laetitia Mais, Nadia Oussaid, et al.
Journal of Geriatric Oncology|July 30, 2019
Use's assessment of geriatric variables in the older patient with cancer's multidisciplinary team meetingEmilien Billon, Louis Tassy, Matthieu Sarabi, et al.
Immunotherapy|September 8, 2021
Immune checkpoint inhibitor sensitivity of DNA repair deficient tumorsPauline Rochefort, Françoise Desseigne, Valérie Bonadona, et al.
The Oncologist|June 6, 2019
Long-Term Survivors in Metastatic Pancreatic Ductal Adenocarcinoma: A Retrospective and Matched Pair AnalysisPauline Rochefort, Audrey Lardy-Cleaud, Matthieu Sarabi, et al.
Frontiers in Immunology|October 17, 2019
Neutrophil Heterogeneity in Cancer: From Biology to TherapiesPacôme Lecot, Matthieu Sarabi, Manuela Pereira Abrantes, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Hepatobiliary Surgery and Nutrition|December 12, 2025
Biliary tract cancers: topaz-1 up-date, a practice changing studyMatthieu Sarabi, Pascal Artru
Bulletin Du Cancer|May 19, 2023
[New drug approval: Durvalumab in combinaison with cisplatin and gemcitabine in first-line in patient with advanced biliary tract cancer]Laure Blondet, Matthieu Sarabi
Joint Bone Spine|June 5, 2013
Online home self-assessment: a tool for improving future treatment trials… and daily practice: comments on the editorial by Berthelot JM, et al. "Online home self-assessment: a tool for improving future treatment trials?", Joint Bone Spine 2013;80:5-7Yvan Jamilloux, Matthieu Sarabi
European Journal of Cancer (Oxford, England : 1990)|December 4, 2022
Cholangiocarcinoma: what are the options in all comers and how has the advent of molecular profiling opened the way to personalised medicine ?Gael S Roth, Cindy Neuzillet, Matthieu Sarabi, et al.
Biomedical Reports|January 27, 2017
Psychoactive drugs influence brain-derived neurotrophic factor and neurotrophin 4/5 levels in the serum of colorectal cancer patientsMatthieu Sarabi, Aurélie Perraud, Clément Mazouffre, et al.
Oncology Letters|June 11, 2017
Use of gemcitabine as a second-line treatment following chemotherapy with folfirinox for metastatic pancreatic adenocarcinomaMatthieu Sarabi, Laetitia Mais, Nadia Oussaid, et al.
Journal of Geriatric Oncology|July 30, 2019
Use's assessment of geriatric variables in the older patient with cancer's multidisciplinary team meetingEmilien Billon, Louis Tassy, Matthieu Sarabi, et al.
Immunotherapy|September 8, 2021
Immune checkpoint inhibitor sensitivity of DNA repair deficient tumorsPauline Rochefort, Françoise Desseigne, Valérie Bonadona, et al.
The Oncologist|June 6, 2019
Long-Term Survivors in Metastatic Pancreatic Ductal Adenocarcinoma: A Retrospective and Matched Pair AnalysisPauline Rochefort, Audrey Lardy-Cleaud, Matthieu Sarabi, et al.
Frontiers in Immunology|October 17, 2019
Neutrophil Heterogeneity in Cancer: From Biology to TherapiesPacôme Lecot, Matthieu Sarabi, Manuela Pereira Abrantes, et al.
Pageof 3